| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701573 | Journal of Thoracic Oncology | 2017 | 7 Pages |
Abstract
Patients who underwent segmentectomy may have survival outcomes no different than those of some patients who received lobectomy for pathological stage IA adenocarcinomas at least 10 but no larger than 20 mm in size. These results should be further confirmed through prospective randomized trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ze-Rui MD, Dong-Rong MD, Rainbow W.H. MbChB., Tony S.K. MD, FRCPC, George G. PhD, Malcolm J. MD, Calvin S.H. MD,